Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
19 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/19/3083940/0/en/Recludix-Pharma-Presents-Data-Demonstrating-Potent-Efficacy-and-High-Selectivity-of-a-STAT6-Inhibitor-in-Preclinical-Asthma-Model.html
07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3076387/0/en/Recludix-Pharma-Presents-Preclinical-Data-on-First-in-Class-BTK-SH2-Domain-Inhibitor-Demonstrating-Powerful-BTK-Inhibition-Exceptional-Selectivity-and-Encouraging-Efficacy-in-a-Mod.html
10 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/10/3023395/0/en/Recludix-Pharma-to-Present-at-the-Oppenheimer-35th-Annual-Healthcare-Life-Sciences-Conference.html
10 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/10/3007632/0/en/Recludix-Pharma-to-Present-at-the-Annual-J-P-Morgan-Healthcare-Conference.html
25 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/25/2986620/0/en/Recludix-Pharma-to-Participate-in-Two-Investor-Conferences-in-December.html
14 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/14/2981350/0/en/Recludix-Pharma-to-Present-Data-Demonstrating-its-Oral-STAT3-Inhibitor-has-Differentiated-Efficacy-and-Safety-as-Compared-to-JAK-TYK2-Inhibition-in-In-Vivo-Models-of-Inflammatory-A.html
ABOUT THIS PAGE